Plants and equipment sit at the core of pharmaceutical and plastics manufacturing operations. From precision fill-finish lines to advanced moulding and extrusion systems, these assets represent significant capital investment and, when managed strategically, can deliver value well beyond their initial operational life.
As global supply chains tighten and production timelines lengthen, manufacturers are increasingly reassessing how they acquire, redeploy, and monetise specialised equipment throughout its lifecycle.
In both pharmaceuticals and plastics, equipment value is driven by precision engineering, regulatory compliance, and production capability. Assets such as blow-fill-seal machines, aseptic packaging lines, injection moulders, and extrusion systems are built to exacting standards and often remain in demand long after their first deployment.
With long lead times for new machinery, secondary markets continue to play a critical role in helping manufacturers access proven equipment faster and more cost-effectively.
A recent pharmaceutical manufacturing project demonstrates how specialist plants and equipment can be successfully repositioned into global markets.
Following the closure of a pharmaceutical production facility, Hilco APAC was engaged to manage the valuation, marketing, and sale of complex manufacturing assets. This included advanced blow-fill-seal equipment that attracted strong international buyer interest and achieved exceptional sales outcomes. Read the full project overview here.
By combining market-based valuation with targeted global marketing, these assets were efficiently redeployed, delivering strong results for the seller while enabling buyers to secure critical production equipment without extended manufacturing lead times.
A more detailed breakdown of the engagement, process, and outcomes can be found in the related case study. View the case study here.
For pharmaceutical and plastics manufacturers alike, secondary markets offer tangible advantages:
• Faster access to operational equipment
• Improved capital efficiency
• Reduced downtime during expansion or transition phases
• Sustainable outcomes through asset reuse
For asset owners, a structured monetisation approach ensures surplus, idle, or end-of-life equipment is positioned to achieve maximum market value.
Maximising returns from plant and equipment requires deep sector knowledge and an understanding of global demand dynamics. Accurate valuation, targeted buyer outreach, and compliance-aware execution are essential, particularly in highly regulated manufacturing environments.
Partnering with specialists who understand both the assets and the industries they serve allows organisations to navigate complex asset decisions with confidence.
Plants and equipment continue to play a pivotal role in pharmaceutical and plastics manufacturing, not just in production, but as strategic assets throughout their lifecycle. With the right expertise and global reach, these assets can deliver measurable value at every stage.
Have an excess, obsolete or returned stock challenge? Talk to us.
Rochelle has forged a career as a Retail inventory specialist over 18 years across auctions, marketplaces, eCommerce and Retail, locally and internationally. Having worked for both high growth start-ups and Australia’s largest retail corporations, Rochelle has seen the myriad of challenges faced by Retailers in complex inventory environments.
As Director, Wholesale at Hilco Global, Rochelle translates this expertise in buying, sourcing and trading, offering clients strategies that can be deployed immediately in solving inventory challenges at scale.
"*" indicates required fields
